(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202406 | 202306 | % Var | 202406 | 202306 | % Var | 202403 | 202303 | % Var | |
| Sales | 0.79 | 0.68 | 16.18 | 0.79 | 0.68 | 16.18 | 5.55 | 10.19 | -45.53 |
| Other Income | 4.57 | 4.57 | 0.00 | 4.57 | 4.57 | 0.00 | 19.92 | 17.51 | 13.76 |
| PBIDT | 1.83 | 1.83 | 0.00 | 1.83 | 1.83 | 0.00 | 9.10 | 10.60 | -14.15 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 1.83 | 1.83 | 0.00 | 1.83 | 1.83 | 0.00 | 9.10 | 10.60 | -14.15 |
| Depreciation | 0.24 | 0.24 | 0.00 | 0.24 | 0.24 | 0.00 | 0.98 | 0.94 | 4.26 |
| PBT | 1.59 | 1.59 | 0.00 | 1.59 | 1.59 | 0.00 | 8.12 | 9.66 | -15.94 |
| TAX | 0.69 | 1.05 | -34.29 | 0.69 | 1.05 | -34.29 | 0.62 | 4.63 | -86.61 |
| Deferred Tax | 0.39 | 0.60 | -35.00 | 0.39 | 0.60 | -35.00 | 0.19 | 2.12 | -91.04 |
| PAT | 0.90 | 0.54 | 66.67 | 0.90 | 0.54 | 66.67 | 7.50 | 5.03 | 49.11 |
| Equity | 49.96 | 49.96 | 0.00 | 49.96 | 49.96 | 0.00 | 49.96 | 49.96 | 0.00 |
| PBIDTM(%) | 231.65 | 269.12 | -13.92 | 231.65 | 269.12 | -13.92 | 163.96 | 104.02 | 57.62 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: